Oral Fecal Microbiota Treatment Reduces CDI Recurrence In High-Risk Patients, Study Finds

Infectious Disease Advisor (8/23, Wei) reports, “Fecal microbiota spores, live-brpk (previously SER-109) significantly reduce the risk for recurrent Clostridioides difficile infection (CDI) when compared with placebo, irrespective of patient characteristi...